scholarly journals Intravenous iron isomaltoside 1000 (Monofer ® ) reduces postoperative anaemia in preoperatively non‐anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double‐blind placebo‐controlled clinical trial (the PROTECT trial)

Vox Sanguinis ◽  
2015 ◽  
Vol 109 (3) ◽  
pp. 257-266 ◽  
Author(s):  
P. I. Johansson ◽  
A. S. Rasmussen ◽  
L. L. Thomsen
Sign in / Sign up

Export Citation Format

Share Document